Intelligent Bio Solutions Inc. Files 10-K/A Amendment
Ticker: INBS · Form: 10-K/A · Filed: Feb 13, 2025 · CIK: 1725430
Sentiment: neutral
Topics: amendment, annual-report, sec-filing
TL;DR
Intelligent Bio Solutions filed an amendment to its 2024 annual report. Check for updates.
AI Summary
Intelligent Bio Solutions Inc. filed an amendment (10-K/A) on February 13, 2025, for its fiscal year ended June 30, 2024. The company, formerly known as GBS Inc., is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry. Its business address is in New York, NY.
Why It Matters
This filing provides updated or corrected information for the company's annual report, which is crucial for investors to understand the company's financial health and operational status.
Risk Assessment
Risk Level: medium — As a 10-K/A filing, it indicates potential corrections or additions to previously filed information, which could signal underlying issues or complexities in the company's reporting.
Key Numbers
- 001-39825 — Commission File Number (Identifies the company's filing with the SEC)
- 0630 — Fiscal Year End (Indicates the end of the reporting period)
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- 001-39825 (company) — Commission File Number
- 20250213 (date) — Filing date of amendment
- 20240630 (date) — Fiscal year end
FAQ
What specific information was amended in this 10-K/A filing?
The filing is an amendment (No. 1) to the annual report for the fiscal year ended June 30, 2024, filed on February 13, 2025. Specific details of the amendments are not provided in the header information.
What was Intelligent Bio Solutions Inc. formerly known as?
Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.
In which state is Intelligent Bio Solutions Inc. incorporated?
Intelligent Bio Solutions Inc. is incorporated in Delaware.
What is the primary business address of Intelligent Bio Solutions Inc.?
The business address is 135 W 41ST ST, FLOOR 5, NEW YORK, NY 10036.
What is the SIC code for Intelligent Bio Solutions Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 3,806 words · 15 min read · ~13 pages · Grade level 9.8 · Accepted 2025-02-13 17:15:32
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share INBS The Nasdaq Stock Ma
Filing Documents
- form10-ka.htm (10-K/A) — 206KB
- ex23-1.htm (EX-23.1) — 6KB
- ex31-3.htm (EX-31.3) — 7KB
- ex31-4.htm (EX-31.4) — 7KB
- ex23-1_001.jpg (GRAPHIC) — 7KB
- 0001493152-25-006477.txt ( ) — 604KB
- inbs-20240630.xsd (EX-101.SCH) — 34KB
- inbs-20240630_lab.xml (EX-101.LAB) — 122KB
- inbs-20240630_pre.xml (EX-101.PRE) — 24KB
- form10-ka_htm.xml (XML) — 9KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INTELLIGENT BIO SOLUTIONS INC. Date: February 13, 2025 By: /s/ Harry Simeonidis HARRY SIMEONIDIS CHIEF EXECUTIVE OFFICER AND PRESIDENT (Principal Executive Officer) Date: February 13, 2025 By: /s/ Spiro Sakiris SPIRO SAKIRIS CHIEF FINANCIAL OFFICER (Principal Financial Officer) Pursuant to the requirements of the Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. Signature Title Date /s/ Harry Simeonidis Chief Executive Officer and President February 13, 2025 Harry Simeonidis (Principal Executive Officer) /s/ Spiro Sakiris Chief Financial Officer February 13, 2025 Spiro Sakiris (Principal Financial Officer) /s/ Steven Boyages Chairman of the Board February 13, 2025 Steven Boyages MBBS, PHD /s/ Jonathan Hurd Director Jonathan Hurd February 13, 2025 /s/ Jason Isenberg Director Jason Isenberg February 13, 2025 /s/ Nicola Fraser Director Nicola Fraser February 13, 2025